You can find the annual or quarterly income statement of NewAmsterdam Pharma Company NV here for insights into the performance and operational efficiency of NewAmsterdam Pharma Company NV.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q3

FY2023Q2

FY2023Q1

Total revenue

-98.80%348.00K

740.06%19.14M

112.56%2.98M

--12.77M

889.83%29.11M

32.73%2.28M

-83.76%1.40M

--2.94M

--1.72M

--8.63M

Revenue

-98.80%348.00K

740.06%19.14M

112.56%2.98M

--12.77M

889.83%29.11M

32.73%2.28M

-83.76%1.40M

--2.94M

--1.72M

--8.63M

Operating expenses

4.74%55.49M

2.05%54.78M

28.42%71.90M

--56.00M

3.43%52.98M

31.83%53.68M

18.48%55.99M

--51.22M

--40.72M

--47.26M

R&D expenses

-13.25%30.97M

-28.30%27.52M

5.47%44.75M

--34.90M

-17.68%35.70M

11.76%38.38M

4.97%42.43M

--43.37M

--34.34M

--40.42M

Depreciation, depletion, and amortization

128.57%64.00K

136.84%45.00K

246.67%52.00K

--51.00K

--28.00K

46.15%19.00K

66.67%15.00K

----

--13.00K

--9.00K

Operating profit

-131.03%-55.14M

30.67%-35.63M

-26.26%-68.92M

---43.23M

50.57%-23.87M

-31.79%-51.40M

-41.32%-54.59M

---48.28M

---39.00M

---38.63M

Net non-operating interest income (expenses)

Non-operating interest income

51.09%6.71M

44.87%7.05M

138.44%7.35M

--4.49M

45.24%4.44M

5.57%4.87M

226.94%3.08M

--3.06M

--4.61M

--943.00K

Gains from sale of securities

-93.85%218.00K

497.33%8.63M

229.66%4.29M

---7.87M

180.07%3.55M

38.93%-2.17M

-279.75%-3.31M

---4.43M

---3.56M

--1.84M

Special income (expenses)

-2989.87%-23.79M

-73.28%2.59M

145.58%17.75M

---45.56M

-130.54%-770.00K

2869.14%9.69M

-530.77%-38.95M

--2.52M

---350.00K

---6.17M

- Gains from disposal of fixed assets

---1.00K

----

Income before tax

-332.51%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Income tax

----

--0.00

---1.00K

--0.00

----

--0.00

Income after tax

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Net income from continuous operations

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Net income attributable to controlling interests

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Net income attributable to common shareholders

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Basic earnings per share

-244.40%-0.61

64.44%-0.15

67.92%-0.34

---0.93

69.26%-0.18

11.73%-0.41

-106.13%-1.06

---0.57

---0.47

---0.51

Diluted earnings per share

-244.40%-0.61

64.44%-0.15

67.92%-0.34

---0.93

69.26%-0.18

11.73%-0.41

-106.13%-1.06

---0.57

---0.47

---0.51

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

